指南与共识质量管理与危急值临床生化

基于患者的实时质量控制:综述与建议

Patient-Based Real-Time Quality Control: Review and Recommendations.
指南 / 共识 · Clin Chem · 2019-07-01

该综述指出基于患者的质控在血液学实验室已应用,但在临床化学中因需针对人群和项目优化而未广泛实施。文章描述了基于患者质控系统的组成(计算算法、区块大小、截断限、控制限)及其与待控分析物的关系,并强调利用本实验室患者数据优化系统以可靠检测系统误差并减少假警报。

要点

  • 基于患者的实时质控利用患者样本数据检测分析误差,包括监测人群参数均值或中位数及delta检查。
  • 系统组成包括计算算法、区块大小、截断限和控制限,需针对每个分析物优化。
  • 需用本实验室患者数据优化系统,以可靠检测系统误差并确保假警报少。

核心结论

  • 基于患者的实时质控可用于检测分析误差,但需针对每个分析物和人群优化,并利用本实验室患者数据减少假警报。

研究设计与样本

  • 综述与建议类文章,来自Clin Chem,讨论基于患者实时质控系统的组成与实施指导。

主要发现

  • 基于患者的质控在血液学实验室已讨论和实施,但在临床化学中未广泛实施。
  • 系统组成包括计算算法、区块大小、截断限和控制限,这些与待控分析物相关。
  • 需用个体检测实验室的患者数据优化系统,以可靠检测系统误差并确保假警报少。

关键数值与推荐

  • 基于患者的实时质控涵盖利用患者样本数据检测分析误差的活动,包括监测人群参数均值或中位数及delta检查。
  • 本报告限于基于人群的参数讨论,不涵盖人群的临床评估。

临床怎么用

  • 实验室可参考本综述实施基于患者的质控系统,利用本实验室患者数据优化参数以检测系统误差并控制假警报。

局限性

  • 基于患者的质控形式复杂,需针对每个人群和每个分析物优化。
  • 报告不涵盖人群的临床评估,且仅讨论基于人群的参数而非单患者内变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For many years the concept of patient-based quality control (QC) has been discussed and implemented in hematology laboratories; however, the techniques have not been widely implemented in clinical chemistry. This is mainly because of the complexity of this form of QC, as it needs to be optimized for each population and often for each analyte. However, the clear advantages of this form of QC, together with the ongoing realization of the shortcomings of "conventional" QC, have driven a need to provide guidance to laboratories to assist in deploying patient-based QC. This overview describes the components of a patient-based QC system (calculation algorithm, block size, truncation limits, control limits) and the relationship of these to the analyte being controlled. We also discuss the need for patient-based QC system optimization using patient data from the individual testing laboratory to reliably detect systematic errors while ensuring that there are few false alarms. The term patient-based real-time quality control covers many activities that use data from patient samples to detect analytical errors. These activities include the monitoring of patient population parameters such as the mean or median analyte value or using single within-patient changes such as the delta check. In this report, we will restrict the discussion to population-based parameters. This overview is intended to serve as a guide for the implementation of a patient-based QC system. The report does not cover the clinical evaluation of the population.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Badrick T, Bietenbeck A, Cervinski MA, et al. Patient-Based Real-Time Quality Control: Review and Recommendations. Clin Chem. 2019. PMID: 31263035. doi:10.1373/clinchem.2019.305482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。